Atricure
ATRC40.4801.00% ( -0.410 )
Atricure (ATRC)
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and...
- Open
- 40.750
- High
- 41.160
- Low
- 40.170
- Prev. Close
- 40.890
- Volume
- 237.22K
- Turnover
- 9.61M
- Avg Price
- 40.519
- Bid/Ask Ratio
- --
- Amplitude
- 2.42%
- 52wk High
- 43.180
- Volume Ratio
- 0.55
- Turnover Ratio
- 0.49%
Atricure Analyst Rating
View MoreForecast & Rating
Jul 28, 2026Price forecast
$47.3316.93%
Forecast & RatingBuy
10analysts
- Strong buy50.00%
- Buy30.00%
- Hold20.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · 1 day ago, 07:45 AM
Top 3 Health Care Stocks That May Implode This Month
- Tip Ranks · 2 days ago, 01:00 AM
Atricure Still Faces Broad, Evolving Risks Despite No Material Changes in 2025 10-K Disclosures
- TradingView · 2 days ago, 12:11 PM
AtriCure, Inc. 2026: Revenue $153.6M, EPS $0.18— 10-Q Summary
- PUBT · 2 days ago, 12:08 PM
AtriCure Q2 net income turns to USD 8.96 million; revenue rises 12.8% to USD 153.6 million year over year
- PUBT · Jul 27 at 07:06 AM
Inspire Medical Systems appoints AtriCure CEO Michael Carrel to board
- PUBT · Jul 27 at 07:00 AM
AtriCure to join Needham Virtual MedTech & Diagnostics investor conference
